Citations

Mayo Clinic

Showing 10 of 108585 citations.

P‐TS‐95 | Type and Screen Orders From the OR: Can This Practice Be Improved?
Klein, M., DiGuardo, Margaret , Nazli, Saadiya, Samaddar, Arkayan , Gerald, D., Tauscher, Craig D. , Klein, M., Chandrasekar, Aswath P. , Samaddar, A.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.432_17554 Get It

P‐TA‐3 | Characterization of Spirometric Response to Therapeutic Plasma Exchange (TPE) and Factors Associated with Respiratory Distress in Myasthenia Gravis Patients
Weli, Homayemem , Fortuny, Lisandro, Shah, Palmi , Hernández, P , Kneiber, Diana , Stamos, Alex, Varadhachary, Atul , Sommerville, R. Brian, Despotis, Grigorios, OʼBrien, Jennifer , Hernandez, P., Kneiber, D., Stamos, A., Varadhachary, A.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.327_17554 Get It

P‐BB‐42 | IgA‐deficient Donors—Screening Process and Data from Three US Centers
Keller, M. , Kavitsky, V., Maurer, J., Gannett, Michael, Marrero, Carlos , Swanson, John A., Tauscher, Craig D. , Facey, D., Keller, M.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.146_17554 Get It

P‐BB‐32 | Effect of COVID‐19 Precautions on Donor Adverse Events (DAE) in the Apheresis Donor Population at a Hospital‐Based Donor Center
Duffy, Kirsten P., Buskirk, Charles Van, Buskirk, Camille M. van , Anderson, Annie S. , Duffy, K., Juskewitch, Justin E.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.136_17554 Get It

P‐BB‐24 | Comparing Cryoprecipitate Fibrinogen Content by Plasma Thawing Technique
Swanson, John A., Soland, Michelle A, Hammel, Stephen, Button, L. N., Hammel, S., Juskewitch, Justin E.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.128_17554 Get It

P‐BB‐6 | A Practical Option for Platelet Shortages: A Warm to Cold Storage Converted Apheresis Platelet Program During the COVID‐19 Pandemic
Hammel, Stephen, Stubbs, James R. , Vrieze, Jop de, Thomas, L., Stensgard, R., Hammel, S., Vrieze, J., Thomas, L., Gandhi, Manish J. , Juskewitch, Justin E.

Transfusion | October 12, 2023 | Volume: 63 | Issue: S5 | Pages: No page available

10.1111/trf.110_17554 Get It

Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU
O’Grady, Naomi P., Alexander, Earnest, Alhazzani, Waleed , Alshamsi, Fayez , Cuellar‐Rodríguez, Jennifer , Jefferson, Brian , Patel, Robin , Deresinski, Stanley C. , Patel, Robin , Kalil, André C. , Pastores, Stephen M. , van Duin, David , Weber, David J.

Critical Care Medicine | October 12, 2023 | Volume: 51 | Issue: 11 | Pages: 1570-1586

10.1097/ccm.0000000000006022 | PMID 37902340 Get It

RATIONALE: Fever is frequently an early indicator of infection and often requires rigorous diagnostic evaluation. OBJECTIVES: This is an update of the 2008 Infectious Diseases Society of America and Society (IDSA) and Society of Critical Care Medicine (SCCM) guideline for the evaluation of new-onset fever in adult ICU patients without severe immunocompromise, now using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. PANEL DESIGN: The SCCM and IDSA convened a taskforce to update the 2008 version of the guideline for the evaluation of new fever in critically ill adult patients, which included expert clinicians as well as methodologists from the Guidelines in Intensive Care, Development and Evaluation Group. The guidelines committee consisted of 12 experts in critical care, infectious diseases, clinical microbiology, organ transplantation, public health, clinical research, and health policy and administration. All task force members followed all conflict-of-interest procedures as documented in the American College of Critical Care Medicine/SCCM Standard Operating Procedures Manual and the IDSA. There was no industry input or funding to produce this guideline. METHODS: We conducted a systematic review for each population, intervention, comparison, and outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the GRADE approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak or as best-practice statements. RESULTS: The panel issued 12 recommendations and 9 best practice statements. The panel recommended using central temperature monitoring methods, including thermistors for pulmonary artery catheters, bladder catheters, or esophageal balloon thermistors when these devices are in place or accurate temperature measurements are critical for diagnosis and management. For patients without these devices in place, oral or rectal temperatures over other temperature measurement methods that are less reliable such as axillary or tympanic membrane temperatures, noninvasive temporal artery thermometers, or chemical dot thermometers were recommended. Imaging studies including ultrasonography were recommended in addition to microbiological evaluation using rapid diagnostic testing strategies. Biomarkers were recommended to assist in guiding the discontinuation of antimicrobial therapy. All recommendations issued were weak based on the quality of data. CONCLUSIONS: The guidelines panel was able to formulate several recommendations for the evaluation of new fever in a critically ill adult patient, acknowledging that most recommendations were based on weak evidence. This highlights the need for the rapid advancement of research in all aspects of this issue—including better noninvasive methods to measure core body temperature, the use of diagnostic imaging, advances in microbiology including molecular testing, and the use of biomarkers.
Comment on “Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study”
Wieruszewski, Patrick M. , Bauer, Seth R. , Bauer, Seth R , Wieruszewski, Patrick M

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | October 12, 2023 | Volume: 43 | Issue: 10 | Pages: 1094-1094

10.1002/phar.2870 | PMID 37823712 Get It

Chloroquine impairs maximal transdiaphragmatic pressure generation in old mice
Saldarriaga, Carlos A., Alatout, Mayar H., Sieck, Gary C. , Mantilla, Carlos B. , Khurram, Obaid U. , Gransee, Heather M , Sieck, Gary , Mantilla, Carlos B , Saldarriaga, Carlos A., Gransee, Heather M.

Journal of Applied Physiology | October 12, 2023 | Volume: 135 | Issue: 5 | Pages: 1126-1134

10.1152/japplphysiol.00365.2023 | PMID 37823202 Get It

Recent findings suggest that autophagy plays a role in the development of aging-related neuromuscular dysfunction; however, the contribution of autophagy impairment to the maintenance of diaphragm force generation in old age is unknown. This study shows that in old mice, chloroquine administration decreases maximal transdiaphragmatic pressure generation. These chloroquine effects suggest a susceptibility to impairments in autophagy in old age.
Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation
Sayyed, Adil Ali , Gondaliya, Piyush , Carrington, James , Driscoll, Julia , Moirangthem, Anuradha, Patel, Tushar , Yan, Irene K. , Carrington, James , Patel, Tushar , Ali Sayyed, Adil

Nanomaterials | October 12, 2023 | Volume: 13 | Issue: 20 | Pages: 2751

10.3390/nano13202751 | PMID 37887902 Get It

Extracellular vesicles (EVs) show promise for targeted drug delivery but face production challenges with low yields. Cell-derived nanovesicles (CDNVs) made by reconstituting cell membranes could serve as EV substitutes. In this study, CDNVs were generated from mesenchymal stem cells by extrusion. Their proteomic composition, in vitro and in vivo toxicity, and capacity for loading RNA or proteins were assessed. Compared with EVs, CDNVs were produced at higher yields, were comprised of a broader range of proteins, and showed no detrimental effects on cell proliferation, DNA damage, or nitric oxide production in vitro or on developmental toxicity in vivo. CDNVs could be efficiently loaded with RNA and engineered to modify surface proteins. The feasibility of generating immunomodulatory CDNVs was demonstrated by preparing CDNVs with enhanced surface expression of PD1, which could bind to PD-L1 expressing tumor cells, enhance NK and T cell degranulation, and increase immune-mediated tumor cell death. These findings demonstrate the adaptability and therapeutic promise of CDNVs as promising substitutes for natural EVs that can be engineered to enhance immunomodulation.